Table 3.
Univariable analysis - pooled data | Model 2 - Mulitvariable model for associations with mortality for complete case analysis including interaction terms for malaria endemicity | Model 3 - Mulitvariable model for associations with mortality on imputed data including interaction terms for malaria endemicity | |||
---|---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | OR (95% CI) | ||
AUC | 0·86 | 0·85 | |||
Pseudo R-squared | 0·25 | 0·24 | |||
Age groupa | |||||
2 _6 months | ref | ||||
7 _11 months | 0·72(0·64–0·82) | <0·001 | |||
12_59 months | 0·40(0·36–0·45) | ||||
2_6 months in high malaria prevalence | ref | ref | |||
7 _11 months in high malaria prevalence | 0·46(0·36–0·60) | 0·43(0·29–0·63) | |||
12_59 months in high malaria prevalence | 0·41(0·33–0·50) | 0·37(0·27–0·50) | |||
7 _11 months in Low malaria prevalence | 0·34(0·15–0·75) | 0·33(0·19–0·57) | |||
12_59 months in Low malaria prevalence | 0·29(0·14–0·62) | 0·29(0·17–0·49) | |||
Child sex | |||||
Female | ref | ref | ref | ||
Male | 0·79(0·72–0·86) | <0·001 | 0·71(0·64–0·80) | 0·67(0·57–0·79) | |
WAZ scorea | |||||
0 or > = 1 SD | ref | ||||
Minus 1 SD | 1·35(1·17–1·56) | <0·001 | |||
Minus 2 SD | 2·26(1·95–2·61) | ||||
Minus 3 SD | 4·35(3·86–4·92) | ||||
0 or > = 1 SD in high malaria prevalence | ref | ref | |||
Minus 1 SD in high malaria prevalence | 1·50(1·15–1·95) | 1·19(0·85–1·67) | |||
Minus 2 SD in high malaria prevalence | 1·25(0·95–1·65) | 1·50(1·03–2·17) | |||
Minus 3 SD in high malaria prevalence | 2·96(2·27–3·86) | 3·01(2·09–4·35) | |||
Minus 1 SD in Low malaria prevalence | 0·93(0·45–1·93) | 1·06(0·61–1·82) | |||
Minus 2 SD in Low malaria prevalence | 1·17 (0·56–2·44) | 0·88(0·52–1·51) | |||
Minus 3 SD in Low malaria prevalence | 2·36(1·13–4·94) | 2·09(1·22–3·56) | |||
Number of comorbidities | |||||
0 | ref | ref | ref | ||
1 | 1·44(1·28–1·62) | <0·001 | 0·99(0·85–1·16) | 1·08(0·86–1·37) | |
2 | 2·21(1·94–2·50) | 1·03(0·86–1·23) | 1·27(0·98–1·64) | ||
> = 3 | 3·67(3·18–4·23) | 1·25(1·02–1·55) | 1·68(1·25–2·25) | ||
History of fever | |||||
No | ref | ref | ref | ||
Yes | 0·96(0·84–1·10) | 0·555 | 0·77(0·66–0·90) | 0·76(0·62–0·92) | |
History of diarrhoea | |||||
No | ref | ref | ref | ||
Yes | 2·02(1·82–2·25) | <0·001 | 1·34(1·16–1·56) | 1·45(1·20–1·76) | |
Convulsions | |||||
No | ref | ref | ref | ||
Yes | 1·13(1·00–1·28) | 0·045 | 1·54(1·32–1·81) | 1·35(1·09–1·67) | |
Vomitting everything | |||||
No | ref | ref | ref | ||
Yes | 1·41(1·25–1·58) | <0·001 | 1·04(0·91–1·20) | 1·03(0·86–1·24) | |
Indrawing | |||||
No | ref | ref | ref | ||
Yes | 2·84(2·55–3·18) | <0·001 | 2·61(2·28–2·98) | 2·48(2·08–2·96) | |
Pallor | |||||
None | ref | ref | ref | ||
Some/severe | 3·39(3·03–3·79) | <0·001 | 2·21(1·93–2·53) | 2·32(1·92–2·81) | |
Central cyanosis | |||||
No | ref | ref | ref | ||
Yes | 6·36(4·54–8·90) | <0·001 | 2·64(1·70–4·12) | 3·25(1·91–5·53) | |
AVPU | |||||
Alert | ref | ref | ref | ||
Not alert (VPU) | 8·95(7·88–10·17) | <0·001 | 3·98(3·31–4·77) | 3·95(3·16–4·95) | |
Ability to drinka | |||||
No | ref | ||||
Yes | 0·23(0·20–0·26) | <0·001 | |||
Ability to drink no in high malaria prevalence | ref | ref | |||
Ability to drink yes in high malaria prevalence | 0·63(0·49–0·80) | 0·65(0·48–0·87) | |||
Ability to drink yes in Low malaria prevalence | 0·51(0·24–1·08) | 0·44(0·25–0·78) | |||
Stiff necka | |||||
No/soft | ref | ||||
Yes | 2·71(2·13–3·44) | <0·001 | |||
Stiff neck no in high malaria prevalence | ref | ref | |||
Stiff neck yes in high malaria prevalence | 2·17(1·38–3·42) | 3·92(2·15–7·16) | |||
Stiff neck yes in low malaria prevalence | 3·07(1·28–7·36) | 1·53(0·81–2·90) | |||
Skin pinch | |||||
Immediate | ref | ref | ref | ||
1–2 s | 2·25(1·96–2·59) | <0·001 | 1·29(1·09–1·52) | 1·17(0·94–1·44) | |
> 2 s | 6·18(5·28–7·24) | 1·80(1·43–2·26) | 1·47(1·09–1·98) | ||
Capillary refill time | |||||
<=2 scs | ref | ref | ref | ||
>3 s | 3·28(2·80–3·84) | <0·001 | 1·46(1·15–1·86) | 1·68(1·32–2·13) | |
Indeterminate | 0·70(0·51–0·97) | 1·17(0·79–1·73) | 1·83(1·12–2·99) | ||
Sunken eyes | |||||
No | ref | ref | ref | ||
Yes | 2·76(2·44–3·12) | <0·001 | 1·12(0·96–1·31) | 1·24(1·00–1·55) | |
Jaundice | |||||
None | ref | ref | ref | ||
Moderate/severe | 2·03(1·55–2·66) | <0·001 | 1·78(1·30–2·42) | 1·64(1·01–2·65) | |
Severe wastinga | |||||
No | ref | ||||
Yes | 5·01(4·32–5·81) | <0·001 | |||
Severe wasting no in high malaria prevalence | ref | ref | |||
Severe wasting yes in high malaria prevalence | 2·35(1·68–3·27) | 2·54(1·70–3·82) | |||
Severe wasting yes in low malaria prevalence | 1·99(0·97–4·09) | 1·66(0·95–2·87) | |||
Oedema of malnutritiona | |||||
None | ref | ||||
Moderate/severe | 3·02(2·39–3·80) | <0·001 | |||
Oedema none in high malaria prevalence | ref | ref | |||
Oedema mild/moderate in high malaria prevalence | 2·66(1·82–3·89) | 3·13(1·95–5·02) | |||
Oedema mild/moderate in Low malaria prevalence | 2·45(1·17–5·13) | 1·88(1·08–3·25) | |||
Malaria endemicity | |||||
High | ref | <0·001 | ref | ref | |
Low | 0·90(0·83–0·99) | 0·71(0·46–1·08) | 0·78(0·43–1·42) | ||
Hospital | |||||
A | ref | ref | ref | ||
B | 1·23(1·01–1·61) | <0·001 | 1·26(0·91–1·73) | 1·69(1·04–2·74) | |
C | 1·83(1·53–2·20) | 1·74(1·30–2·32) | 1·90(1·26–2·85) | ||
D | 2·46(2·04–2·96) | 1·53(1·16–2·01) | 1·99(1·33–2·98) | ||
E | 0·53(0·39–0·72) | 0·60(0·40–0·90) | 0·53(0·28–1·00) | ||
F | 1·00(0·79–1·26) | 0·91(0·66–1·26) | 0·88(0·56–1·39) | ||
G | 0·48(0·34–0·67) | 0·75(0·49–1·15) | 0·81(0·43–1·50) | ||
H | 1·41(1·14–1·76) | 0·83(0·62–1·11) | 0·90(0·52–1·57) | ||
I | 1·43(1·20–1·72) | 1·23(0·98–1·55) | 1·15(0·82–1·60) | ||
J | 1·08(0·86–1·37) | 0·68(0·50–0·92) | 1·05(0·68–1·63) | ||
K | 1·52(1·25–1·84) | 0·82(0·64–1·07) | 0·95(0·68–1·32) | ||
L | 1·40(1·15–1·70) | na | na |
Model 2 results are based on complete case analysis while model 3 results are based on the imputed dataset; both models include interaction terms for malaria prevalence.
aVariables with significant interactions with malaria endemicity